Metabolic syndrome and liver disease in the era of bariatric surgery: What you need to know!

Metabolic syndrome and liver disease in the era of bariatric surgery: What you need to know! World J Hepatol. 2020 Oct 27;12(10):709-721 Authors: Ziogas IA, Zapsalis K, Giannis D, Tsoulfas G Abstract Metabolic syndrome (MS) is defined as the constellation of obesity, insulin resistance, high serum triglycerides, low high-density lipoprotein cholesterol, and high blood pressure. It increasingly affects more and more people and progressively evolves into a serious issue with widespread healthcare, cost, and quality of life associated consequences. MS is associated with increased morbidity and mortality due to cardiovascular or chronic liver disease. Conservative treatment, which includes diet, exercise, and antidiabetic agents, is the mainstay of treatment, but depends on patient compliance to medical treatment and adherence to lifestyle modification recommendations. Bariatric surgery has recently emerged as an appropriate alternative treatment with promising long-term results. Sleeve gastrectomy and Roux-en-Y gastric bypass constitute the most commonly performed procedures and have been proven both cost-effective and safe with low complication rates. Liver transplantation is the only definitive treatment for end-stage liver disease and its utilization in patients with non-alcoholic steatohepatitis has increased more than fivefold over the past 15 years. In this review, we summarize current state of evidence on the surgical treatment o...
Source: World Journal of Hepatology - Category: Gastroenterology Tags: World J Hepatol Source Type: research